Back to Pre-formulation
Novartis

Pre-formulation

In this course we will focus on how active compounds are developed into a formulation suitable for dosing in animal studies and early human clinical trials.  Factors such as the route of administration, enhancing the solubility of the drug substance, the crystalline form of the drug substance, drug substance vs. drug product, storage requirements, and how special requirements of the patient population play a role in the design of an ideal formulation will be covered.  Finally, some of the differences encountered when formulating a biologic vs. a small molecule will be discussed. Target audience: This course is suitable for life scientists, clinicians, and individuals from fields that support drug discovery (e.g., patents, finance, licensing, etc.) interested in learning more about the pharmaceutical/biotechnology sector. Advanced undergraduate coursework or practical familiarity/working knowledge in biological sciences and organic chemistry is recommended.

Status: Clinical Trials
Status: Pharmacology
IntermediateCourse8 hours

Featured reviews

CK

Reviewed Jul 2, 2025

This course is well-structured to help people understand the drug development process

All reviews

Showing: 11 of 11

Tirth
Reviewed Oct 26, 2024
Crystal
Reviewed Jul 3, 2025
Al-Shahriar
Reviewed Oct 14, 2024
ARE
Reviewed Nov 24, 2025
Sarah
Reviewed Jul 5, 2025
VYDANI
Reviewed Nov 24, 2024
Gaurav
Reviewed Sep 7, 2026
Suchit
Reviewed Apr 19, 2026
Michael
Reviewed May 7, 2025
Ajay
Reviewed Feb 22, 2026
Shea
Reviewed Nov 9, 2025